The KLOW 80mg vial contains KPV 10mg (Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone at residues 11 to 13, 342.4 g/mol, CAS 64790-08-5), BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in one container
Co Formulation Study Design and Participants The study design and participant demographics of the cagrilintide and semaglutide trial were meticulously planned to ensure reliable results
May 2012;26(5):554-559
Is VivePeptides GHK-Cu third-party tested
See Example 1

Galactomyces Ferment Filtrate, Glycerin, Cetyl Ethylhexanoate, Propanediol, Dicaprylyl Carbonate, 1, 2-Hexanediol, Betaine, Cetearyl Alcohol, Polyglyceryl-10 Laurate, Methyl Trimethicone, Silica, Cetearyl Olivate, Panthenol, Phenyl Trimethicone, Potassium Cetyl Phosphate, Water, Sorbitan Olivate, Bisabolol, Ammonium Polyacryloyldimethyl Taurate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, 3-O-Ethyl Ascorbic Acid, Glutathione, Ethylhexylglycerin, Fragrance, Lavandula Angustifolia (Lavender) Oil, Coptis Japonica Root Extract, Xanthan Gum, Butylene Glycol, Adenosine, Fructooligosaccharides, Sorbitan Isostearate, T-Butyl Alcohol, Hydrogenated Lecithin, Beta-Glucan, Hydrolyzed Hyaluronic Acid, Ascorbic Acid, Tocopherol, Allantoin, Ceramide NP, Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Bran Extract, Glyceryl Stearate, Phytosphingosine, Cholesterol, Ceramide AP, Ceramide AS, Ceramide NS, Caprylyl Glycol, Ceramide NG, Ceramide EOP, Linalool, Limonene Ingredients may change
